Short answer
PROCEPT BioRobotics Corp (PRCT) filed an 8-K current report with the SEC on October 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Board expanded from 9 to 10 directors, adding governance capacity and an independent voice.
PROCEPT BioRobotics Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expanded from 9 to 10 directors, adding governance capacity and an independent voice
- Dr. Michael Mack appointed Class II director, serving through the 2029 annual meeting
- Extensive cardiac-surgery and medical-device leadership strengthens clinical credibility and potential physician engagement
- Standard non-employee director compensation and indemnification arrangements, with no reported conflicts or related-party transactions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PROCEPT BioRobotics Corp 8-K filings
Get the next PRCT 8-K as it lands
Follow PRCT for push alerts, or ask the research agent what this filing means.